Welcome to our second newsletter covering exciting updates on 02H and our sector to our clients and friends! Skilled outsourcing to India has continued to gain momentum with companies around the globe – and with its large and youthful demographic, India is starting to be regarded as one of the “workforces of the world”. It is clear that an India strategy is on the agenda of all pharmaceutical and biotechnology companies both large and small – but now the world is also now on the agenda of Indian biopharma companies. India has built on its historical strengths in manufacturing and generics to press aggressively into provision of research services. With strong performance on the Bombay Stock Exchange, publicly listed Indian biopharma companies are diversifying into product development programmes of their own and making aggressive overseas acquisitions. It is clear that India will have a leading role to play in future development programmes as it integrates itself further into the global biopharma economy. In this climate, O2H is poised to build on its unique position in providing high-quality outsourced services from India to the global biopharma industry. We’ve continued to progress well in recent months, adding a number of globally renowned pharmaceutical companies to our growing list of biotechnology clients. We’ve welcomed a number of new clients taking their first steps in India with 02H and are even more pleased to report that our existing clients have deepened their current relations with us. It’s an exciting journey and we hope you enjoy this latest installment of our news and views!
Sunil & Prashant
 |
O2H has now worked with 19 clients from around the world including Japan, USA, and Europe. The company is in the process of expanding its capacity with a purpose-built laboratory in an upcoming Special Economic Zone in India which will have single window customs clearance amongst other advantages. The new larger facility will allow 02H to extend its relationships with its clients by offering more customised and collaborative partnership options for its clients. Our service offering includes synthetic and medicinal chemistry, natural product extraction, route development and focused library generation. | |
“As Oxygen Healthcare Research (O2H) was undertaking a critical project for Amura, I was invited over to undertake some technology transfer which was critical for a patent that our company is filing, spending a week in their lab facility in Gujarat. When I first saw to the lab, I was surprised and impressed with the quality of the equipment that the company had purchased since their inception. The labs are well set up and the chemists have all the necessary equipment required to do synthetic chemistry on milligram to multigram scales.
By Marc B. Brown - CSO MedPharm
Over the past 40 years, the US pharmaceutical industry’s inflation-adjusted research and development spend has increased from $2.5 billion to $27 billion. However, the number of new chemical entities (NCEs) produced per year in the US has only doubled. In the early 60s, this equated to an average of $179 million per drug against a conservative estimate of $843 million per NCE in 2000.
Read the full DDT article by Marc B Brown, CSO of MedPharm
02H has continued to develop its project management office in the Cambridge Science Park in the UK with the addition of Tejas Upadhyay as a Scientific Liaison Officer – significantly strengthening our chemistry expertise in the UK. Tejas’s role includes an accelerated technical assessment of new projects and a faster face-to-face resolution of chemistry-related problems between the team and our clients. He completed his PhD in India and then worked for an Indian research company before going on to undertake a post-doc at Glasgow University in Scotland.
02H Sport – Cricket
Every quarter O2H brings you a taste of India from Gujarat!
This quarter we hope to briefly divert readers from the beginning of the European football season with a snap shot on O2H cricket. India is a country obsessed with cricket and O2H is doing its best to uphold this great national passion!
Every alternate Friday before work, the team plays cricket an intensely fought game of cricket! It’s a great team building activity and a chance for our scientists to show their sporting prowess!
Click here to see a wicket being taken and a technically perfect hook shot.
O2H Conferences
We’re committed to spreading the word about our fantastic
service offering and finding out what is happening in the biopharma industry
around the world. So over the next few months 02H will be exhibiting at some key
events across the globe. We’d be delighted to meet you at any of the following
events if you are attending and encourage you to
send us an email if you’re going to be there. We look forward to meeting you!
| O2H Attending CPhI |
| 4 October at the Paris-Nord Villepinte. |
|
O2H Exhibiting at Bench to Boardroom 2006 |
| 18 October at Chilford Hall Vineyear and Conference Centre, Cambridge, UK |
|
O2H Attending CHI's Drug Development in India |
| Nov. 16-17, 2006, Boston Park Plaza, Boston |
11-12 December Queen Elizabeth II Conference Centre, London
O2H
Exhibiting at Biotrinity 2007
28 March at The Oxford Belfry Hotel
O2H at ERBI 2006 –
Birthday Beers
02H would like to thank Cobra for
sponsoring its first birthday celebrations at the ERBI conference, Cambridge, UK
– a great time was had by all!
Click here for your chance to win a FREE case of Cobra Beer
